27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Shares of Conatus Pharmaceuticals (NASDAQ: CNAT) are up more than nine percent in Monday’s premarket session in a sympathy move to Intercept Pharmaceuticals (NASDAQ: ICPT).
After Monday’s close, Intercept reported endpoints were met in a trial testing obeticholic acid to treat liver. In addition, Intercept reported better than expected second quarter earnings. Following a series of analyst upgrades, shares of Intercept are no up 45 percent in the premarket session.
Similarly, Conatus is working to treat a series of liver diseases. The surge higher in Intercept shares is likely encouraging to Conatus’s solution and leads to industry revaluation.
Conatus shares were last up 9.4 percent while Intercept shares had gained 47 percent.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!